First Quarter 2021 Earnings Presentation

May 4, 2021

Safe Harbor Statement and Other Matters

This presentation contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance, business plans, prospects, targets, goals and commitments, capital investments and projects, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward- looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets. The full extent and impact of the pandemic is unknown and to date has included extreme volatility in financial and commodity markets, a significant slowdown in economic activity, and increased predictions of a global recession. The public and private sector response has led to significant restrictions on travel, temporary business closures, quarantines, stock market volatility, and a general reduction in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may or may continue to limit travel of employees to our business units domestically and internationally, adversely affect the health and welfare of our personnel, significantly reduce the demand for our products, hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S.

Securities and Exchange Commission, including in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 and in our Annual Report on Form 10-K for the year ended December 31, 2020.

We prepare our financial statements in accordance with Generally Accepted Accounting Principles ("GAAP"). Within this presentation we may make reference to Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow, Adjusted Effective Tax Rate, Return on Invested Capital (ROIC) and Net Leverage Ratio which are non-GAAP financial measures. The company includes these non-GAAP financial measures because management believes they are useful to investors in that they provide for greater transparency with respect to supplemental information used by management in its financial and operational decision making. Further information with respect to and reconciliations of such measures to the nearest GAAP measure can be found in the appendix hereto.

Management uses Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow, Adjusted Effective Tax Rate, ROIC and Net Leverage Ratio to evaluate the company's performance excluding the impact of certain noncash charges and other special items which we expect to be infrequent in occurrence in order to have comparable financial results to analyze changes in our underlying business from quarter to quarter.

Additional information for investors is available on the company's website at investors.chemours.com.

2

First Quarter 2021 Highlights

Delivered strong topline growth; capitalized on recovery across all end-markets and regions

Achieved strong margin and cash flow despite weather and logistics challenges

Increased full-year 2021 Adjusted EBITDA and Free Cash Flow guidance by $100 million

Executing on strategic objectives including portfolio optimization and commercial excellence

Announced ambitious net zero greenhouse gas emissions goal

3

Net Zero Operations Greenhouse Gas Emissions Goal

Replaces prior 2030 intensity and 2050 net positive climate goals

2030

Our Strengthened

Climate Goal

Achieve 60%

Absolute Reduction

of CO2e Emissions

from Operations1

On a Journey to

Achieve Net-Zero CO2e

Emissions from Operations1 by

2050

  • Aligns with Paris Agreement 1.5°C goal
  • Sets a science-based target
  • Will be realized by process emissions reductions, energy efficiency, increased use of renewable energy

1 Scope 1 and 2 emissions

4

First Quarter 2021 Financial Summary

($ in millions unless otherwise noted)

Year-Over-Year

1Q21

1Q20

Yr/Yr

Net sales of $1.4 billion increased 10% vs.

-

Net Sales

$1,436

$1,305

$131

the prior-year first quarter, reflecting

Net Income1

$96

$100

($4)

strength in the recovery and demand

momentum from Q4

Adj. Net Income

$120

$118

$2

-

EPS of $0.57, with adjusted EPS of $0.71

EPS2

$0.57

$0.61

($0.04)

-

Adjusted EBITDA was $268 million, an

Adj. EPS2

$0.71

$0.71

$0.00

increase of $11 million vs. the prior-year

quarter

Adj. EBITDA

$268

$257

$11

-

Adjusted EBITDA Margin was 19%, 1

Adj. EBITDA Margin (%)3

19

20

(1)

percentage point lower vs. the prior year

Free Cash Flow4

($21)

($62)

$41

-

Free Cash Flow for the first quarter was

negative $21 million, a $41 million

improvement vs. the prior-year Free Cash

Flow outflow of negative $62 million

See reconciliation of Non-GAAP measures in the Appendix

1

Net Income attributable to The Chemours Company

2

Calculation based on diluted share count

3

Defined as Adjusted EBITDA divided by Net Sales

4

Defined as Cash from Operations minus cash used for PP&E purchases

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

The Chemours Company published this content on 04 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 May 2021 11:36:08 UTC.